Insider Trading & Ownership - Poulton Stuart

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Poulton Stuart
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-07-30
Sale
2024-07-31
4:14 pm
Karyopharm Therapeutics Inc.KPTIPoulton Stuart
EVP, Chief Development Officer
2,883$1.06$3,056326,628
(Direct)
View
2024-02-29
Sale
2024-03-04
7:40 pm
Karyopharm Therapeutics Inc.KPTIPoulton Stuart
EVP, Chief Development Officer
22,466$1.1782$26,470329,511
(Direct)
View
2024-02-15
Sale
2024-02-20
4:59 pm
Karyopharm Therapeutics Inc.KPTIPoulton Stuart
EVP, Chief Development Officer
5,847$1.3312$7,783163,772
(Direct)
View
2023-07-28
Sale
2023-08-01
5:37 pm
Karyopharm Therapeutics Inc.KPTIPoulton Stuart
EVP, Chief Development Officer
2,845$1.7$4,837156,286
(Direct)
View
2023-02-15
Sale
2023-02-17
4:07 pm
Karyopharm Therapeutics Inc.KPTIPoulton Stuart
EVP, Chief Development Officer
5,869$3.1891$18,71764,131
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-28
Option Award
2024-02-29
5:35 pm
N/A
N/A
Karyopharm Therapeutics Inc.KPTIPoulton Stuart
EVP, Chief Development Officer
188,205$0351,977
(Direct)
View
2024-01-24
Option Award
2024-01-25
7:14 pm
N/A
N/A
Karyopharm Therapeutics Inc.KPTIPoulton Stuart
EVP, Chief Development Officer
13,333$0169,619
(Direct)
View
2023-02-28
Option Award
2023-03-02
5:38 pm
N/A
N/A
Karyopharm Therapeutics Inc.KPTIPoulton Stuart
EVP, Chief Development Officer
95,000$0159,131
(Direct)
View

Ownership
2022-08-19
4:15 pm
N/A
N/A
Karyopharm Therapeutics Inc.KPTIPoulton Stuart
EVP, Chief Development Officer
0$0180,000
(Direct)
View